Prolonged delivery of nicotine in rats via nasal administration of proliposomes

Journal of Controlled Release

Volumn 66, Issue 1, 2000, Pages 73-79

  Jung, Byung Hwa ^a,b   Chung, Bong Chul ^b   Chung, Suk Jae ^a   Lee, Min Hwa ^a   Shim, Chang Koo ^a  

^a Seoul National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Nicotine; Nicotine hydrogen tartarate; Proliposomes; Prolonged nasal delivery

Indexed keywords

COTININE; LIPOSOME; NICOTINE; NICOTINE TARTRATE; SORBITOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG HALF LIFE; DRUG METABOLISM; MALE; MEAN RESIDENCE TIME; NONHUMAN; PARTICLE SIZE; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LIPOSOMES; MALE; NICOTINE; NICOTINIC AGONISTS; PARTICLE SIZE; PHARMACEUTICAL SOLUTIONS; POWDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034600195     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00258-8     Document Type: Article

References (26)

1. Schievelbein H. Barfour D.J.K. Nicotine and the Tobacco Smoking Habit. 1984;1-15 Pergamon Press, Oxford.
2. Benowitz N.L. Pharmacokinetic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med. 319:1988;1318-1330.
3. Porchet H.C., Benowitz N.L., Sheiner L.B. Pharmacodynamic model of tolerance: Application to nicotine. J. Pharmacol. Exp. Ther. 244:1988;231-236.
4. Benowitz N.L. Pharmacodynamics of nicotine: Implications for rational treatment of nicotine addiction. Br. J. Addict. 86:1991;495-499.
5. Zins B.J., Sandborn W.J., May D.C., Lawson G.M., Mckinney J.A., Tremaine W.J., Mahoney D.W., Zinsmeister A.R., Hurt R.D., Offord K.P., Lipsky J.J. Pharmacokinetics of nicotine tartarate after single-dose liquid enema, oral and intravenous administration. J. Clin. Pharmacol. 37:1997;426-436.
6. Pullan R.D., Rodes J., Ganesh S., Mani V., Morris J.S., Willams G.T., Newcombe R.G., Russell M.A., Feyerabend C., Tomas G.A., Säwe W. Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330:1994;811-815.
7. Sandborn W.J., Tremaine W.J., Offord K.P., Lawson G.M., Petersen B.T., Batts K.P., Croghan I.T., Dale L.C., Schroeder D.R., Hurt R.D. Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126:1997;364-371.
8. Newhouse P.A., Sunderland I., Tariot P.N., Blumhardt C.L., Weingatner H., Mellow A., Murphy D.L. Intravenous nicotine in Alzheimer's disease: pilot study. Psychopharmacology. 95:1988;171-175.
9. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry. 154:1989;797-800.
10. Barn J.A. Cigarette smoking and Parkinson's disease. Neurology. 36:1988;1490-1496.
11. Newhouse P.A., John H.R. The role of nicotine and nicotine mechanisms in neuropsychiatric disease. Br. J. Addict. 86:1991;521-526.
12. Ferre M., Cami J. Pharmacokinetics considerations in abuse liability evaluation. Br. J. Addict. 86:1991;1601-1606.
13. Henningfield J.F., Keenan R.M. Nicotine delivery kinetics and abuse liability. J. Consult. Clin. Psychol. 61:1993;743-750.
14. ® (nicotine transdermal system). J. Clin. Pharmacol. 33:1993;169-174.
15. Schneider N.G., Lunell E., Stead R.E.O., Fagerstöm K.O. Clinical pharmacokinetics of nasal nicotine delivery. Clin. Pharmacokinet. 31:1996;65-80.
16. Sutherland G., Russell M.A.H., Stapleton J., Feyerabend C., Ferno O. Nasal nicotine spray: a rapid nicotine delivery system. Psychopharmacology. 108:1992;512-518.
17. Johansson C.J., Olsson P., Bende M., Carlsson T., Gunnarsson P.O. Absolute bioavailability of nicotine applied to different nasal region. Eur. J. Clin. Pharmacol. 41:1991;585-588.
18. Ahn B.N., Kim S.K., Shim C.K. Proliposomes as an intranasal dosage form for the sustained delivery of propranolol. J. Control. Release. 34:1995;203-210.
19. B.H. Jung, B.C. Chung, S.J. Chung, M.H. Lee, C.K. Shim, Different pharmacokinetics of nicotine base and nicotine hydrogen tartarate due to different rate of metabolic conversion to cotinine in rats. Eur. J. Drug Metab. Pharmacokinet. (submitted).
20. Hwang B.Y., Jung B.H., Chung S.J., Lee M.H., Shim C.K. In vitro skin permeation of nicotine from proliposomes. J. Control. Release. 49:1997;177-184.
21. Berner B., Mazzenga G.C., Gargiulo P.M., Steffens R. A transdermal nicotine system: Feasibility studies. J. Control. Release. 20:1992;13-20.
22. Hussain A., Hirai S., Barsarschi R. Nasal absorption of propranolol in rats. J. Pharm. Sci. 68:1979;1196.
23. Jung B.H., Chung B.C., Chung S.J., Lee M.H., Shim C.K. Simultaneous GC-MS determination of nicotine and cotinine in plasma for pharmacokinetic characterization of nicotine in rats. J. Pharm. Biomed. Anal. 20:1999;195-202.
24. Prather R.D., Tu T.G., Rolf C.N., Gorsline J. Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men. J. Clin. Pharmacol. 33:1993;644-649.
25. Di Cob G., Carelli V., Giannaccini B., Serafini M.F., Bottari F. Vehicles effects in percutaneous absorption; In vitro study of influence of solvent powder and microscopic viscosity of vehicles on benzocaine release from suspension hydrogels. J. Pharm. Sci. 69:1980;387-391.
26. Williams D.E., Ding X., Coon M.J. Rabbit nasal cytochrome P-450 NMa high activity as a nicotine oxidase. Biochem. Biophys. Res. Commun. 166:1990;945-952.